The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8748418, 13::US8748418, 21 ID: ALA3670915
Chembl Id: CHEMBL3670915
PubChem CID: 66547489
Max Phase: Preclinical
Molecular Formula: C23H24F3N5O
Molecular Weight: 443.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)OCC(N)=N[C@](C)(c2cc(N[C@@H]3CCc4cc(C#N)cnc43)ccc2F)C1(F)F
Standard InChI: InChI=1S/C23H24F3N5O/c1-21(2)23(25,26)22(3,31-19(28)12-32-21)16-9-15(5-6-17(16)24)30-18-7-4-14-8-13(10-27)11-29-20(14)18/h5-6,8-9,11,18,30H,4,7,12H2,1-3H3,(H2,28,31)/t18-,22-/m1/s1
Standard InChI Key: JAWQNPDVHXPUOL-XMSQKQJNSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 443.47Molecular Weight (Monoisotopic): 443.1933AlogP: 4.21#Rotatable Bonds: 3Polar Surface Area: 96.32Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.42CX LogP: 3.14CX LogD: 2.83Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.74Np Likeness Score: -0.50
References 1. (2014) 1,4-oxazepines as BACE1 and/or BACE2 inhibitors,